The investigation of TRPV1’s involvement in autoimmune conditions such as systemic lupus erythematosus, multiple sclerosis, and rheumatoid arthritis highlights its potential as a therapeutic target. The gene discussed is TRPV1; the disease is systemic lupus erythematosus.